Biomarkers in SCOTland CardiomyopatHy Registry (Bio-SCOTCH)

Recruiting now

Conditions studied: Cardiomyopathies, Genetic Predisposition, Cardiomyopathy, Primary

In brief

Genetic cardiomyopathy is increasingly recognised and can lead to heart failure, arrhythmia and sudden cardiac death. Some gene positive patients have rapidly progressive disease with high rates of heart failure and cardiac transplantation, while others present with SCD. Other gene positive patients will never develop cardiomyopathy. At present, we cannot distinguish between these groups and rely on expensive and labour-intensive surveillance by electrocardiography, echocardiography and sometimes cardiac magnetic resonance imaging. This study will investigate existing and novel biomarkers (including blood, urine electrocardiographic and imaging) at various stages of disease in patients with a personal or family history of TTN, MYBPC3, LMNA, FLNC or DSP gene variant, which are known to cause cardiomyopathy.

Key facts

Study ID
NCT06446271
Run by
NHS Greater Glasgow and Clyde
People needed
750
Starts
2024-06-26
Expected to finish
2027-03-19
Last updated by the study team
2024-07-03

Who can join

Age: 10 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.